Crinetics Pharmaceuticals
CRNX
CRNX
79 hedge funds and large institutions have $546M invested in Crinetics Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
41% more funds holding
Funds holding: 56 → 79 (+23)
10.82% more ownership
Funds ownership: 84.92% → 95.74% (+11%)
Holders
79
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$35.6M | |
| 2 | +$26.1M | |
| 3 | +$18.8M | |
| 4 |
BlackRock
New York
|
+$18.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$17.3M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$8.76M | |
| 3 | -$7.23M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.36M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$804K |